A J Apperloo
Overview
Explore the profile of A J Apperloo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Dijk S, Scharloo M, Kaptein A, Thong M, Boeschoten E, Grootendorst D, et al.
Nephrol Dial Transplant
. 2009 Apr;
24(10):3183-5.
PMID: 19383834
Background: Self-regulation theory explains how patients' illness perceptions influence self-management behaviour (e.g. via adherence to treatment). Following these assumptions, we explored whether illness perceptions of ESRD-patients are related to mortality...
2.
van Loo I, van den Wildenberg W, van Huijstee P, Roukema J, Apperloo A, Peeters M
J Med Microbiol
. 2007 Nov;
56(Pt 12):1684-1686.
PMID: 18033839
Arcanobacterium haemolyticum has usually been isolated in cases of pharyngitis and wound infections. Rarely it has been reported to cause deep tissue infections. Here, a case of a 71-year-old-male, who...
3.
van Essen G, Apperloo A, Rensma P, Stegeman C, Sluiter W, de Zeeuw D, et al.
Kidney Int Suppl
. 1998 Jan;
63:S58-62.
PMID: 9407423
We questioned the superiority of angiotensin converting enzyme (ACE) inhibitors to beta blocking drugs with regard to renal function outcome in patients with mild to moderate renal insufficiency and normal...
4.
Apperloo A, de Zeeuw D, de Jong P
Kidney Int
. 1997 Mar;
51(3):793-7.
PMID: 9067912
In long-term intervention studies on renal function outcome an initial decline in the glomerular filtration rate (GFR) may occur after starting therapy. If this initial GFR decline is the result...
5.
Apperloo A, Rensma P
N Engl J Med
. 1996 Aug;
335(8):596-7; author reply 597.
PMID: 8684417
No abstract available.
6.
Apperloo A, de Zeeuw D, Donker A, de Jong P
J Am Soc Nephrol
. 1996 Apr;
7(4):567-72.
PMID: 8724890
In studies on the progression of chronic renal failure the measurement of GFR must be very reliable. Sequential determination of GFR using the renal clearances of exogenous tracers such as...
7.
van Essen G, Rensma P, de Zeeuw D, Sluiter W, Scheffer H, Apperloo A, et al.
Lancet
. 1996 Jan;
347(8994):94-5.
PMID: 8538349
Background: Polymorphism in the gene for angiotensin-converting enzyme (ACE), especially the DD genotype, is associated with risk for cardiovascular disease. Glomerulosclerosis has similarities to atherosclerosis, and we looked at ACE...
8.
Apperloo A, de Zeeuw D, de Jong P
Clin Pharmacol Ther
. 1994 Dec;
56(6 Pt 1):647-58.
PMID: 7995007
Objective: To investigate whether there are quantitative differences between the angiotensin converting enzyme (ACE) inhibitors enalapril and lisinopril with respect to their influence on renal versus systemic hemodynamics in humans....
9.
Apperloo A, de Zeeuw D, de Jong P
Kidney Int Suppl
. 1994 Feb;
45:S174-8.
PMID: 8158890
No abstract available.
10.
Rensma P, Apperloo A, de Jong P
Lancet
. 1992 Dec;
340(8833):1479-80; author reply 1480-1.
PMID: 1360605
No abstract available.